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Abstract
Microinjection is a gene transfer technique enabling partial control of plasmid delivery into the nucleus or
cytoplasm of cultured animal cells. Here this method was used to establish various recombinant mam-
malian cell lines. The injection volume was estimated by ﬂuorescence quantiﬁcation of injected ﬂuorescein
isothyocynate (FITC)-dextran. The DNA concentration and injection pressure were then optimized for
microinjection into the nucleus or cytoplasm using a reporter plasmid encoding the green ﬂuorescent
protein (GFP). Nuclear microinjection was more sensitive to changes in these two parameters than was
cytoplasmic microinjection. Under optimal conditions, 80–90% of the cells were GFP-positive 1 day after
microinjection into the nucleus or the cytoplasm. Recombinant cell lines were recovered following
microinjection or calcium phosphate transfection and analyzed for the level and stability of recombinant
protein production. In general, the eﬃciency of recovery of recombinant cell lines and the stability of
reporter protein expression over time were higher following microinjection as compared to CaPi trans-
fection. The results demonstrate the feasibility of using microinjection as a method to generate recombinant
cell lines.
Introduction
The time consuming and labor intensive process
of establishing a recombinant cell line involves
the isolation, characterization, and expansion of
a clonal cell line from a pool of transfected cells.
The most commonly used non-viral transfection
methods are calcium phosphate-DNA coprecipi-
tation (CaPi), lipofection, and polyfection
(Graham & Eb 1973, Jordan et al. 1996, Thomas
& Klibanov 2003). All three rely on the forma-
tion of positively charged nanoparticles which
enter cells after binding to the cell surface. None
of these methods, however, allows control of the
amount and the subcellular location of the DNA
delivered into each individual cell. In contrast,
microinjection of plasmid DNA does provide
control over these two parameters, and each
microinjected cell can be observed and analyzed
for early gene expression and cell growth.
Microinjection is a common technique for intro-
ducing genes into eggs to generate transgenic
animals (Brinster et al. 1985). It is also used for
gene transfer into cells that are diﬃcult to trans-
fect such as vascular smooth muscle cells and
mesenchymal stem cells (Nelson & Kent 2002,
Tsulaia et al. 2003). Furthermore, it has been
used to study plasmid DNA degradation, trans-
port, and integration (Folger et al. 1982, Dean
1997, Lechardeur et al. 1999). With Chinese
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hamster ovary (CHO) DG44 cells as the host
and green ﬂuorescent protein (GFP) as the re-
porter, we have investigated several critical
parameters of DNA microinjection to evaluate
its eﬃcacy for the establishment of recombinant
cell lines. The eﬀects of DNA concentration,
injection pressure, and the subcellular location
of the injection on transgene expression were
evaluated. Within 1 month after microinjection,
recombinant CHO cell lines stably expressing
GFP were recovered, validating this technique as
a potential approach to gene transfer for re-
combinant cell line generation.
Materials and methods
Cell culture
Suspension-adapted CHO DG44 cells (Urlaub
et al. 1983) were maintained in serum-free
ProCHO5 CDM medium (BioWhittaker Inc.,
Walkersville, MD) supplemented with 4 mM glu-
tamine, 0.68 mg/l hypoxanthine, and 0.194 mg/l
thymidine (HT). The culture was agitated at
120 rpm in square-shaped glass bottles on an
orbital shaker in a 37 C incubator (Muller et al.
2005).
Plasmids
The enhanced GFP gene from pEGFP-N1 (Clon-
tech, Palo Alto, CA) was cloned as an EcoRI/
NotI fragment into EcoRI/NotI-digested pMY-
KEF-1 (kindly provided by Dr Y. S. Kim,
Korean Research Institute of Bioscience and Bio-
technology) (Kim et al. 2002) to produce pMY-
KEF1-EGFP. pMYKEF1-EGFP-puro was
generated by cloning the puromycin resistance
gene as a PvuII/HpaI fragment from pEAK8
(EdgeBiosystems, Gaithersburg, MD) into pMY-
KEF1-EGFP digested with BspH1 and PvuII.
pDsRed-Express encoding the red ﬂuorescent
protein (RFP) was purchased from Clontech.
Plasmid DNA was puriﬁed on a Nucleo-
bondAX anion exchange column (Mache-
rey–Nagel GmbH, Du¨ren, Germany) according
to the manufacturers protocol and stored at
1 mg/ml in water at )20 C. For some transfec-
tions pMYKEF1-EGFP-puro was linearized by
digestion with PvuI as indicated.
Microinjection
Microinjection was performed semi-automatically
with a FemtoJet (Eppendorf AG, Hamburg,
Germany) attached to an InjectMan NI 2 (Ep-
pendorf) mounted on an Axiovert 200M inverted
ﬂuorescence microscope (Carl Zeiss AG, Oberko-
chen, Germany). Femtotips II (Eppendorf) with
an inner diameter of 500 nm and an outer diame-
ter of 700 nm were used for all injections. Each
tip was used for the injection of 20–40 cells. The
injection time was kept constant at the lowest set-
ting possible (0.1 s), and the injection angle was
45. A constant compensatory pressure of 30 hPa
was applied to the capillary. One day prior to
microinjection the cells were transferred to
60 mm Petri dishes at 5 104 cells/ml in DMEM/
F12 medium supplemented with HT, 25 mM HE-
PES buﬀer (pH 7.1), and 5% (v/v) fetal calf ser-
um (FCS). Alternatively, the cells were diluted to
5–10 cells per 20 ll in DMEM/F12 medium with
10% (v/v) FCS, and several 20 ll droplets were
deposited on a 60 mm Petri dish. After the cells
adhered (about 4 h) 4 ml of DMEM/F12 medium
supplemented with HT, 10% FCS, and 25 mM
HEPES buﬀer (pH 7.1) were added to each dish.
The latter method was used when cell colonies
were to be recovered from the plate. Usually
50–100 cells per dish were injected over a period
of 30–45 min at room temperature, and the med-
ium was immediately exchanged with fresh pre-
warmed DMEM/F12 medium containing either
5% or 10% FCS and penicillin (10 000 units/ml),
streptomycin (10 mg/ml), and amphotericin B
(25 lg/ml). The percentage of GFP-positive cells
was determined 1 day after injection.
Quantiﬁcation of injection volume
One hundred and ﬁfty kilodaltons FITC-dextran
(Fluka Chemie AG, Buchs, Switzerland) at 5 mg/
ml in water was injected into cells over a
range of injection pressures from 70–100 hPa.
The injection volume was related to the ﬂuores-
cence based on pixel intensity quantiﬁed with
LabVIEW IMAQ Vision (National Instruments,
Austin, TX). A calibration curve was established
by injecting equal volumes having different con-
centrations of FITC-dextran. Based on linear
regression analysis of the standard curve, the
injection volume was estimated by injecting cells
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with 0.5% FITC-dextran. Image acquisition fol-
lowed the exchange of the medium with phos-
phate buffered saline (PBS) to avoid interference
from medium autoﬂuorescence and FITC-dextran
leakage from the capillary. The ﬂuorescence
intensity of each individual cell was then quanti-
ﬁed using the equation of the standard curve.
Fluorescence microscopy
Fluorescence was recorded with an AxioCam HR
camera mounted on an Axiovert 200M ﬂuores-
cence microscope (Carl Zeiss AG). FITC and
GFP ﬂuorescence were analyzed using a ﬁlter
with an excitation wavelength of 485 nm and an
emission wavelength of 515–565 nm. Image
acquisition was controlled by Axiovision 4.1 soft-
ware (Carl Zeiss AG). RFP was analyzed using a
ﬁlter with an excitation wavelength of 545 nm
and an emission wavelength of 605.
Generation of recombinant cell lines by calcium
phosphate transfection
For transfection with calcium phosphate, an opti-
mized protocol for adherent cells was used
(Jordan & Wurm 2004). Brieﬂy, at 4 h prior to
transfection suspension cells were plated at
4.5 106 cells/ml in a 12-well plate in DMEM/
F12. After incubation with the calcium phosphate-
DNA precipitate at 37 C for 3–4 h, the cells were
exposed to 10% glycerol in PBS for 1 min. After
removal of the glycerol solution, the cells were
washed once with 5 mM EGTA in PBS for 1 min.
After removal of the EGTA, pre-warmed
DMEM/F12 supplemented with HT and 5% FBS
was added. At two days post-transfection, 1–4
104 cells were transferred into a Petri dish and
cultivated in DMEM/F12 supplemented with HT,
5% FCS and either 3 or 6 lg puromycin/ml. After
10 days colonies of approximately 100 cells were
transferred into multi-wells plates and cultivated
in the presence of puromycin for 14 weeks.
Generation of recombinant cell lines
by microinjection
Immediately after microinjection, the medium
was exchanged with a mixture of pre-conditioned
and fresh DMEM/F12 at a ratio of either 1:1 or
1:3 (v/v). FCS was added to a ﬁnal concentration
of 10%. The pre-conditioned DMEM/F12 med-
ium was recovered from a 5-day-old culture of
CHO DG44 cells. At day 4 post-microinjection,
puromycin was added to give 3 lg/ml.
Characterization of recombinant cell lines
Every 1–2 weeks the speciﬁc ﬂuorescence was
determined by ﬂuorometry. Cells that had been
cultured for 3 days were transferred in 1 ml to a
12-well microtiter plate in DMEM/F12 medium
and lysed by addition of 1% Triton X-100 in
PBS. The relative ﬂuorescence was measured
with a Cytoﬂuor 4000 plate-reading ﬂuorometer
(PerSeptive Biosystems, Farmingham, MA). The
excitation wavelength was 485 nm with a band-
width of 20 nm, and the emission ﬂuorescence
was measured at 530 nm with a bandwidth of
25 nm. Relative ﬂuorescence units (RFU) were
determined by subtraction of the background ﬂu-
orescence from non-transfected cells. The cell
density was assessed with the CASY1 TTC cell
counter (Scha¨rfe System GmbH, Reutlingen,
Germany). The speciﬁc ﬂuorescence corre-
sponded to the relative ﬂuorescence units divided
by the number of cells multiplied by 100.
Results
Estimation of injection volume
To study the effect of plasmid copy number on
the efﬁciency of gene delivery by microinjection,
it was ﬁrst necessary to develop an assay to mea-
sure the injection volume. The volume is affected
by several parameters including the viscosities of
both the DNA solution and the recipient cellular
compartment as well as the injection time and
pressure. Since cellular viscosity cannot be con-
trolled and the injection time in these experi-
ments was kept constant, the injection volume
and thus the number of plasmid copies delivered
to each cell can be varied either by decreasing
the concentration of the DNA or by varying the
injection pressure. To estimate the volume of an
injection, a solution with a known concentration
of 150-kDa FITC-conjugated dextran was in-
jected into cells over a range of injection pres-
sures. This marker was chosen because it cannot
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freely diffuse through nuclear pores, it is not
cytotoxic at the concentrations used here, and it
is stable for more than 24 h after injection
(Pepperkok et al. 1988). The ﬂuorescence result-
ing from each injection was then used to estimate
the injection volume (Figure 1a–d). Over the
range of injection pressures tested (70–100 hPa),
the average injection volume in CHO DG44 was
found to be 180 femtoliter for nuclear injection
and 180–350 femtoliter for cytoplasmic injection
(Figure 1e). For injection into the cytoplasm, an
increase in the injection pressure resulted in high-
er injection volumes (Figure 1e). In contrast, no
major variation of the injection volume with
increasing pressure was observed for microinjec-
tion into the nucleus (Figure 1e). Following
nuclear injection at 100 hPa a homogenous dis-
tribution of FITC-dextran throughout the cell
was frequently observed, possibly indicating
damage to the nuclear membrane (Figure 1b).
The presence of these cells in the microinjected
population resulted in a reduction of the upper
quartile of the injection volumes (Figure 1e).
Eﬀect of injection pressure and DNA
concentration on gene transfer eﬃciency
A successful injection was visible with phase-
contrast microscopy as a stream in the nucleus
for nuclear injections and as a wave throughout
the cell for cytoplasmic injections. An excessive
volume change in either the nucleus or the cyto-
plasm was correlated with a low probability of
cell survival. Indeed, microscopic observations of
cell volume changes were often accompanied
by massive bubbling of the plasma membrane.
These cells did not survive beyond 1 day post-
microinjection.
The effect of plasmid copy number on the efﬁ-
ciency of gene transfer by microinjection was
determined by injecting cells with various concen-
trations of pMYKEF1-EGFP-puro ranging from
1.8 to 30 lg/ml at injection pressures that were
varied in 10 hPa increments from 70 to 100 hPa.
This range of pressures was selected because
injection at less than 70 hPa yielded little or no
DNA transfer into cells and injection at greater
than 100 hPa resulted in signiﬁcant levels of cell
damage as described above. For cytoplasmic
microinjection the highest eﬃciency of gene trans-
fer was observed at a DNA concentration of
30 lg/ml over a range of injection pressures from
70 to 90 hPa (Figure 2a). This corresponded to a
plasmid copy number of approximately 9000.
Similar results were observed following microin-
jection of cells at a DNA concentration of 15 lg/
ml at pressures from 70 to 80 hPa (Figure 2a).
For DNA concentrations lower than 15 lg/ml,
the eﬃciency of DNA transfer was lower than
60% at all injection pressures tested (Figure 2a).
% j
Fig. 1. Analysis of injection volume. CHO DG44 cells were injected in the nucleus (a and b) or the cytoplasm (c and d) with
FITC-dextran. The injection pressure was either 70 hPa (a and c) or 100 hPa (b and d). Images were acquired immediately after
microinjection using identical exposure times. The scale bar is equivalent to 20 lm and is the same for all the images. (e) Quantiﬁ-
cation of injection volume by ﬂuorescence measurement after microinjection of FITC-dextran into the nucleus or the cytoplasm.
Each bar represents the average of 20–50 injected cells. The upper error bars represent the value for the upper quartile and the
lower error bars represent the value for the lower quartile. Thus, between the upper and lower error bars are the ﬂuorescence val-
ues for 50% of the injected cells.
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By ﬂuorescence microscopy, it was evident at
1 day after injection that the decrease in the per-
centage of GFP-positive cells at the lower DNA
concentrations was accompanied by a decrease in
GFP expression. After cytoplasmic microinjection
at DNA concentrations of 7.5 and 15 lg/ml
(Figure 3a, b), most of the positive cells were
expressing a higher level of GFP than observed
following microinjection at a DNA concentration
of 3.7 lg/ml (Figure 3c).
Fig. 2. Microinjection at various DNA concentrations and injection pressures. The cells were injected with pMYKEF1-EGFP-puro
in the cytoplasm (a) or the nucleus (b). Cells expressing GFP were counted 1 day after microinjection. Each bar represents the
average of four independent experiments each with 25 injected cells.
Fig. 3. GFP expression in microinjected cells. The cells were injected in the cytoplasm (top panels) or in the nucleus (bottom pan-
els) with pMYKEF1-EGFP-puro at concentrations of 15 lg/ml (a, d), 7.5 lg/ml (b, e), or 3.7 lg/ml (c, f) and observed after
1 day. The image acquisition time was constant. The scale bar equals 20 lm and is the same for all images.
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In contrast to the results with cytoplasmic
microinjection, the highest DNA transfer efﬁ-
ciency after nuclear microinjection (90%) was
observed with DNA at 3.7 lg/ml at an injec-
tion pressure of 70 hPa (Figure 2b). This corre-
sponded to an injection of about 900 plasmid
molecules. In general, the lowest DNA transfer
eﬃciencies resulted from microinjection of the
highest concentrations of DNA (15 and 30 lg/
ml) (Figure 2b). GFP-positive cells that were in-
jected with the highest DNA concentrations did
not retain the typical cellular morphology and
they did not divide (Figure 3d). By reducing the
DNA concentration to 7.5 lg/ml, the GFP-posi-
tive cells retained a more typical morphology
(Figure 3e). However, microinjection at this
DNA concentration appeared still to have a neg-
ative eﬀect on the cell as judged by their round-
ing and loss of adherence. GFP-positive cells
resulting from microinjection at a DNA concen-
tration of 3.7 lg/ml underwent cell division and
retained a normal morphology (Figure 3f). In
these cells, GFP expression was detected as early
as 2 h post-injection and was higher than that
observed following microinjection into the cyto-
plasm under any conditions tested (data not
shown).
Recombinant protein expression in real time
Time lapse image acquisition was performed fol-
lowing co-microinjection of cells with 0.5%
FITC-dextran and pDsRed-Express encoding
RFP to allow the estimation of the injection vol-
ume and the real-time monitoring of re-
combinant protein expression. As shown in
Figure 4, four cells were injected in the nucleus
(N1–N4) and one in the cytoplasm (C1) at a
DNA concentration of 15 lg/ml with an injec-
tion pressure of 70 hPa. The cytoplasmic injec-
tion resulted in fusion of this cell (C1) with N4.
RFP expression in the fused cells was initially
observed between 2 and 3 h post-microinjection
(Figure 4, upper right panel). For the other three
cells, variations in the injection volume were ob-
served (Figure 4, upper left panel). Surprisingly,
for the two cells, which received the lowest
amount of FITC-dextran and plasmid (N2 and
N3), RFP expression was observed between 1
and 2 h after microinjection (Figure 4, upper
Fig. 4. Time lapse image acquisition after microinjection of cells with 0.5% FITC-dextran and pDsRed-Express. Cells were micro-
injected in the nucleus (N) or the cytoplasm (C) (upper left panel). RFP was visualized using the bandpass (BP) Zeiss ﬁlter set #43
(excitation: 545 nm and BP 25; emission 605 nm and BP 70). The time post-microinjection is shown in the upper left corner of
each image. The exposure time was constant (100 ms) for each acquisition. The time is reported in hours and minutes. The scale
bar (10 lm) is the same for all images.
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middle panel). For the cell injected with the
highest amount of FITC-dextran (N1), RFP
expression was ﬁrst observed between 5 to 6 h
after microinjection (Figure 4, lower middle pa-
nel). Furthermore, this cell either started to di-
vide but was blocked in mitosis, or was dying
(Figure 4, lower right panel). These observations
correlate with the results observed in Figure 3.
Delivery of a high level of plasmid did not result
in a greater number of RFP-positive cells nor in
higher recombinant protein expression.
Establishment of recombinant cell lines
For the establishment of recombinant cell lines,
the cells were plated in individual droplets (20 ll)
each with about 5–10 cells. Only one of the cells
originating from each droplet was microinjected
with either circular or linear pMYKEF1-EGFP-
puro at concentrations of 30 lg/ml in the cyto-
plasm or 3.7 lg/ml in the nucleus at a pressure of
70 hPa. The cells were maintained in the presence
of puromycin from day 4 post-microinjection.
For nuclear and cytoplasmic microinjection, 47%
and 44% of the cells, respectively, expressed GFP
1 day after microinjection (Table 1). For most of
the GFP-positive cells, ﬂuorescence decreased be-
low the level of detection between 6 and 10 days
after microinjection (data not shown). At 8 days
post-microinjection, about 13% of the GFP-posi-
tive cells were present as colonies regardless of
the subcellular site of microinjection (Table 1).
Cells of these colonies were transferred with pip-
ette tips to microtiter plates. By 22 days after
microinjection, only four of these remained alive.
Thus, the rate of recovery of recombinant cell
lines was about 3–4% for both nuclear and cyto-
plasmic microinjection (Table 1). The four cell
lines were maintained as adherent cultures for
2 months in the absence of puromycin. During
this period three of the four showed little varia-
tion in the level of speciﬁc GFP expression as
determined by ﬂow cytometry (data now shown)
and ﬂuorometry (Figure 5).
For comparison, CHO DG44 cells were trans-
fected with either circular or linear pMYKEF1-
EGFP-puro using CaPi, and the cells were
exposed to either a low (3 lg/ml) or a high
(6 lg/ml) concentration of puromycin. After
10 days of selection, the total number of surviv-
ing colonies of greater than 20 cells was deter-
mined (Table 2). For three of the four
experimental conditions tested, most of the puro-
mycin-resistant colonies did not express a detect-
able level of GFP as judged by ﬂuorescence
microscopy (Table 2). However, almost all of the
antibiotic-resistant colonies following transfection
with linear pMYKEF1-EGFP-puro and selection
in a high concentration of puromycin were ﬂuo-
rescent (Table 2). Overall, the eﬃciency of recov-
ery of GFP-positive recombinant cell lines
following CaPi transfection was less than that
observed for microinjection (Table 2). For each
of the four conditions tested for CaPi transfec-
tion, the highest GFP producer was maintained
in culture without selection pressure for 8 weeks.
Three of the four cell lines displayed a progres-
sive decrease of speciﬁc GFP expression with
time (Figure 6).
Discussion
Here we have shown the potential for the genera-
tion of recombinant cell lines following microin-
jection of plasmid DNA into the nucleus or
) lg p y /
Table 1. Analysis of recombinant cell lines derived by microinjection.
DNA Site of
injection
No. cells inject. aNo. GFP-positive
cells
bNo. GFP-positive
colonies (>20 cells)
cNo. recomb. cell lines Eﬃciency of
cell line generation (%)
Linear Nucleus 30 16 3 1 3.3
Linear Nucleus 25 11 3 1 4
Circular Nucleus 28 12 3 1 3.6
Linear Cytoplasm 25 11 3 1 4
aDetermined at 1 day post-microinjection.
bDetermined at 8 days post-microinjection (4 days of selection).
cDetermined at 22 days post-microinjection (18 days of selection).
379
cytoplasm of CHO DG44 cells. In three of the
four cell lines examined over a period of two
weeks, recombinant protein expression was sta-
ble. The time necessary to generate a cell line
was 3–4 weeks from the time of microinjection.
This was more rapid than has typically been ob-
served for the recovery of recombinant cell lines
following DNA transfection (usually 5–8 weeks).
Thus, microinjection appears to be a promising
approach for the rapid establishment of re-
combinant cell lines. However, further compari-
sons need to be made among the various gene
delivery methods to verify the efﬁciency of re-
combinant cell line recovery.
As a general rule, we observed that the con-
centration of DNA injected into cells had a dra-
matic impact on the gene transfer efﬁciency and
the reporter protein expression level. For cyto-
plasmic microinjection, the highest percentage of
GFP-positive cells and the highest level of GFP
expression were achieved with a DNA concentra-
tion of 30 lg/ml. In contrast, the most successful
nuclear injections were executed with a 10-fold
lower DNA concentration. One major diﬀerence
between the two subcellular sites of injection is
that DNA introduced into the nucleus is immedi-
ately available for transcription whereas DNA
introduced into the cytoplasm must ﬁrst be
transported into the nucleus. Three main factors
aﬀect DNA transport into the nucleus. Cytoplas-
mic DNA is subject to enzymatic degradation
(Lechardeur et al. 1999, Pollard et al. 2001).
However, increasing the level of cytoplasmic
DNA may saturate the nucleases (Pollard et al.
2001). Second, transport of DNA into the
nucleus may take place only during mitosis after
the breakdown of the nuclear membrane
(Brunner et al. 2000, Grosjean et al. 2002). Lastly,
active transport of the DNA from the cytoplasm
to the nucleus via interactions with DNA binding
proteins targeted to the nucleus may be necessary
as discussed in more detail below (Dean 1997).
One recombinant cell line was established after
cytoplasmic microinjection of plasmid DNA. This
was an important observation since it was techni-
cally easier to inject DNA into the cytoplasm
than the nucleus. Others have reported an
absence of reporter gene expression in either
mouse or human cells after microinjection into
the cytoplasm (Capecchi 1980, Mirzayans et al.
1992). However, binding of transcription factors
to the promoter of a mammalian expression
Fig. 5. Cell speciﬁc GFP ﬂuorescence of recombinant cell
lines established after microinjection. The cell lines were gen-
erated by microinjection of linear DNA into the nucleus (n
and m), circular DNA into the nucleus (e), or linear DNA
into the cytoplasm (d).
Table 2. Analysis of recombinant cell lines derived by calcium phosphate transfection.
DNA Puromycin
[lg/ml]
No. cells
selected
aNo.
colonies
aNo. GFP-positive
colonies (>20 cells)
bEﬃciency of
cell line
generation (%)
Circular 3 10 000 1000 57 0.6
Circular 6 20 000 2000 100 0.5
Linear 3 20 000 1900 39 0.2
Linear 6 40 000 700 627 1.5
aDetermined after 10–11 days of selection.
bBased on the number of GFP-positive colonies.
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vector may greatly facilitate transport of the plas-
mid DNA from the cytoplasm to the nucleus
(Dean 1997, Vacik et al. 1999). pMYKEF1-
EGFP-puro carries both the murine cytomegalo-
virus major immediate early promoter and the
human herpes simplex virus thymidine kinase
promoter. It is possible that either one or both of
these DNA elements may have facilitated the
transport of the plasmid to the nucleus.
For the determination of the plasmid copy
number during microinjection, we developed a
ﬂuorescence based quantiﬁcation of the injection
volume. Possibly due to viscosity differences
among individual cells, the injection volume var-
ied up to two-fold even under the same condi-
tions of injection time and pressure. With our
approach we were able to estimate the variation
of the injection volume from one cell to another.
However, we observed that under otherwise iden-
tical conditions, the volume for nuclear injections
was less than that for cytoplasm injections. This
was assumed to be due to a higher viscosity in
the nucleus than in the cytoplasm.
The droplet method used for plating cells
prior to microinjection presented several advan-
tages. It was easier to identify the cell to be
injected, and the cell density was low enough to
avoid overgrowth of the injected cells by the
non-injected cells. Since only one cell was
injected in each droplet, the GFP-positive colo-
nies were not mixed with other injected cells. The
main difﬁculty in this approach was the initiation
of cell growth after injection. This problem was
solved by the addition of conditioned medium
derived from 5-day-old CHO DG44 cell cultures.
The efﬁciency of stable transfection or stable
cell line recovery is a matter of deﬁnition. This
value was easier to determine for microinjection
than for CaPi-mediated transfection since the
number of cells injected was known and each
injected cell was analyzed for GFP expression.
By considering the number of colonies resulting
from each CaPi transfection, we determined the
efﬁciency of stable transfection to be around
10%. However, since the recombinant protein
(GFP) was visually detectable, we could redeﬁne
the stable transfection efﬁciency as the percent-
age of GFP-positive colonies in the population of
transfected cells. In this case, the number was
typically 10 times lower than the total number of
colonies surviving selection in puromycin for
10 days. When considering only GFP-positive
colonies, we observed 3–6 fold higher stable
transfection efﬁciency by microinjection as com-
pared to CaPi-mediated transfection. Further-
more, in our cell lines we observed a more stable
recombinant protein production after microinjec-
tion than after CaPi transfection. Thus, microin-
jection may be an interesting approach to quickly
isolate recombinant cell lines stably expressing
high levels of protein product.
In conclusion, microinjection appears to be a
promising gene transfer method for the establish-
ment of recombinant mammalian cell lines. Be-
sides controlling the amount and subcellular
location of DNA delivery, microinjection also al-
lows the co-delivery of enzymes such as DNA re-
combinases (Bode et al. 2000), viral DNA
integrases (Tanaka & Komuro 2005) or even
restriction enzymes (Manivasakam et al. 2001) to
enhance the probability of exogenous DNA inte-
gration into the host genome.
Acknowledgements
We thank Dr David Hacker for critically read-
ing the manuscript. We thank Dr Claudio
Fig. 6. Cell speciﬁc GFP ﬂuorescence of recombinant cell
lines after CaPi transfection. The cell lines were generated by
transfection of circular (d and n) or linear DNA (m and e)
and isolated after selection with either 3 (n and e) or 6 (d or
m) lg puromycin/ml.
381
Denoya for his advice. This work was sup-
ported by Pﬁzer Inc.
References
Bode J, Schlake T, Iber M, Schubeler D, Seibler J, Snezhkov E,
Nikolaev L (2000) The transgeneticist’s toolbox: novel
methods for the targeted modiﬁcation of eukaryotic
genomes. Biol. Chem. 381: 801–813.
Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter
RD (1985) Factors aﬀecting the eﬃciency of introducing
foreign DNA into mice by microinjecting eggs. Proc. Natl.
Acad. Sci. 82: 4438–4442.
Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner
E (2000) Cell cycle dependence of gene transfer by
liploplex, polyplex and recombinant adenovirus. Gene Ther.
7: 401–407.
Capecchi MR (1980) High eﬃciency transformation by direct
microinjection of DNA into cultured mammalian cells. Cell
22: 479–488.
Dean DA (1997) Import of plasmid DNA into the nucleus is
sequence speciﬁc. Exp. Cell Res. 230: 293–302.
Folger KR, Wong EA, Wahl G, Capecchi MR (1982) Patterns
of integration of DNA microinjected into cultured mamma-
lian cells: evidence for homologous recombination bet-
ween injected plasmid DNA molecules. Mol. Cell Biol. 2:
1372–1387.
Graham FL, Eb AJ van der (1973) A new technique for the
essay of the infectivity of human adenovirus 5 DNA.
Virology 52: 456–467.
Grosjean F, Batard P, Jordan M, Wurm F (2002) S-phase
synchronized CHO cells show elevated transfection eﬃciency
and expression using CaPi. Cytotechnology 38: 57–62.
Jordan M, Schallhorn A, Wurm FM (1996) Transfecting
mammalian cells: optimization of critical parameters aﬀect-
ing calcium phosphate precipitate formation. Nucleic Acids
Res. 24: 596–601.
Jordan M, Wurm F (2004) Transfection of adherent and
suspended cells by calcium phosphate.Methods 33: 136–143.
Kim SY, Lee JH, Shin HS, Kang HJ, Kim YS (2002) The
human elongation factor 1 alpha (EF-1 alpha) ﬁrst intron
highly enhances expression of foreign genes from the
murine cytomegalovirus promoter. J. Biotechnol. 93:
183–187.
Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M,
Graham RW, Beatty B, Squire J, O’Brodovich H, Lukacs
GL (1999) Metabolic instability of plasmid DNA in the
cytosol: a potential barrier to gene transfer. Gene Ther. 6:
482–497.
Manivasakam P, Aubrecht J, Sidhom S, Schiestl RH (2001)
Restriction enzymes increase eﬃciencies of illegitimate DNA
integration but decrease homologous integration in mam-
malian cells. Nucleic Acids Res. 29: 4826–4833.
Mirzayans R, Aubin RA, Paterson MC (1992) Diﬀerential
expression and stability of foreign genes introduced into
human ﬁbroblasts by nuclear versus cytoplasmic microin-
jection. Mutat. Res. 281: 115–122.
Muller N, Girard P, Hacker DL, Jordan M, Wurm FM (2005)
Orbital shaker technology for the cultivation of mammalian
cells in suspension. Biotechnol. Bioeng. 89: 400–406.
Nelson PR, Kent KC (2002) Microinjection of DNA into the
nuclei of human vascular smooth muscle cells. J. Surg. Res.
106: 202–208.
Pepperkok R, Schneider C, Philipson L, Ansorge W (1988)
Single cell assay with an automated capillary microinjection
system. Exp. Cell Res. 178: 369–376.
Pollard H, Toumaniantz G, Amos JL, Avet-Loiseau H,
Guihard G, Behr JP, Escande D (2001) Ca2+-sensitive
cytosolic nucleases prevent eﬃcient delivery to the nucleus of
injected plasmids. J. Gene Med. 3: 153–164.
Tanaka AS, Komuro K (2005) Targeted rearrangement of a
chromosomal repeat sequence by transfection of a homol-
ogous DNA sequence using puriﬁed integrase. Gene Ther.
12: 783–794.
Thomas M, Klibanov AM (2003) Non-viral gene therapy:
polycation-mediated DNA delivery. Appl. Microbiol. Bio-
technol. 62: 27–34.
Tsulaia TV, Prokopishyn NL, Yao A, Carsrud ND, CarouMC,
Brown DB, Davis BR, Yannariello-Brown J (2003) Glass
needle-mediated microinjection of macromolecules and
transgenes into primary human mesenchymal stem cells.
J. Biomed. Sci. 10: 328–336.
Urlaub G, Kas E, Carothers AM, Chasin LA (1983) Deletion
of the diploid dihydrofolate reductase locus from cultured
mammalian cells. Cell 33: 405–412.
Vacik J, Dean BS, Zimmer WE, Dean DA (1999) Cell-speciﬁc
nuclear import of plasmid DNA. Gene Ther. 6: 1006–1014.
382
